Quick links:
Webinar: What’s New in EPP & XLP Research? The PATHWAY Clinical Study of PORT-77
November 12, 2026
4:30 p.m. PT / 7:30 p.m. ET.
VIA Zoom
Presenter: Missy Vadnais, PhD, VMD, Senior Director of Clinical Development and Medical Affairs at GondolaBio
Join GondolaBio to learn about PATHWAY, a clinical study evaluating PORT-77 as a potential treatment for EPP and XLP.
The webinar will explore:
Current research in EPP and XLP
The science behind PORT-77
What GondolaBio has learned from earlier clinical research
An overview of the PATHWAY clinical study
PORT-77 is an investigational medicine and has not been approved by any regulatory authority.
Attendance is free but registration is required at the link below
What is Porphyria
Porphyria is a family of rare disorders related to the way your body makes an important molecule called heme. Some types of porphyria can cause attacks with severe abdominal pain, nausea, and paralysis. Other types cause intense pain, burning or blistering when skin is exposed to sun and some indoor lights. It can take years, sometimes decades to get a diagnosis, and during that time someone with porphyria may be told that their pain and symptoms are “all in their head”.
Porphyria can affect all parts of your life. Beyond the physical illness, having a rare disease can be lonely. Porphyria can make it hard to work or maintain relationships or even spend time outside. Getting a diagnosis or follow up care can be a struggle. We’re here to help.
How We Help
-

Advocacy
Helping you get timely access to appropriate treatments by making sure patient and caregiver’s needs and perspectives are included decisions about drug approval and reimbursement.
-

Awareness
Raising awareness of porphyria and its impacts using social media, patient stories and outreach to medical professionals.
-

Information and Support
Providing one-on-one and group support and resources to people who have or are seeking a porphyria diagnosis.
-
Donate and Support Us
-
Become a Member
-
Get our Newsletter
Everyone living with porphyria has a unique story to tell.
Our Partners